Diet Ratings
Approximately 13g net carbs per tablespoon, primarily sucrose. Liquid sugar form makes portion control difficult and ketosis incompatible.
Pure plant-based sweetener derived from maple tree sap. Minimally processed and fully compliant with vegan standards.
Concentrated sugar product with minimal nutritional advantage over refined sugar. Not available to most Paleolithic populations.
Concentrated sweetener with high sugar content and minimal nutritional benefit. Not traditional to Mediterranean cuisine and contradicts principles of minimal added sugars.
Plant-derived tree sap concentrate. Pure carbohydrate with no animal origin. Incompatible with carnivore diet.
Maple syrup is a concentrated sweetener classified as added sugar and explicitly excluded from Whole30.
Maple syrup contains excess fructose and is high in sugars. Monash University rates maple syrup as high-FODMAP due to fructose content.
Concentrated sugar source (67g sugar per 100ml). Contains some minerals (manganese, zinc) but insufficient to offset added sugar burden. DASH restricts added sugars; maple syrup is a primary source.
High-glycemic carbohydrate (GI ~54-68). Primarily sucrose and glucose. Contains polyphenols but insufficient to offset rapid blood sugar elevation. Incompatible with Zone's low-glycemic carb requirement.
Contains polyphenols and minerals (manganese, zinc) with modest antioxidant activity. However, glycemic impact is similar to honey. The anti-inflammatory benefit from polyphenols is modest relative to sugar content. Better than refined sugar but not a health food.
iSome nutritionists emphasize maple syrup's mineral content and polyphenol profile as meaningfully anti-inflammatory. Others argue the glycemic load negates these benefits for most individuals, particularly those with metabolic dysfunction.
Maple syrup is 13g sugar per tbsp with minimal protein, fiber, or micronutrients. Triggers blood sugar spikes and GLP-1 side effects. No meaningful nutritional advantage over other sweeteners. Empty calories inappropriate for GLP-1 patients with severely reduced caloric intake.
Controversy Index
Score range: 1–9/10. Higher controversy = more disagreement between diets.